NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

If no TLD + publication in Q1 we can all assume journalS have refused the publication and we can start write off our investment, which I absolutely do not expect.

Wouldn't a reasonable person have said the same thing about the fourth quarter of 2021? Or even the third quarter of 2021? How long after locking data and becoming unblinded does it take to release TLD? People have been saying the same thing for years, that if we didn't have TLD in 2020 we could write off our investment. Hell, the company itself has promised TLD numerous times over the years going back to 2007, and did so three times in 2021. This is not new. I'm telling you, this has happened over and over again and it never changes. It never will.

They are not going to release this data. The data does not show what they want it to show, for whatever reason, and they are not having any success trying to change the rules, the endpoints, and the comparative data, all after the fact.

But you know what's even more amazing? After Q1 2022 passes with no data, the same crowd will still be here making excuses - there might even be a few new ones depending on whether NWBO's PR firm enlists some more iHub handles. Guaranteed. After Q1 we'll be talking about the ASM, and then ASCO again. It's Groundhog Day in NWBO land because no one wants to snap out of their delusional dream and acknowledge the obvious truth.